The therapeutic potential of adenosine triphosphate as an immune modulator in the treatment of HIV/AIDS: A combination approach with HAART

Current HIV Research

Volumn 9, Issue 4, 2011, Pages 209-222

  Wagner, Marc C E ^a  

^a NONE   (United States)

Author keywords

ATP; HIV; Inflammasome; Purinergic signaling

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CD39 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CYCLIC AMP; CYTOKINE; EXTRACELLULAR ADENOSINE TRIPHOSPHATE; IMMUNOMODULATING AGENT; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; NITRIC OXIDE; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; THROMBOSPONDIN 1; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIGEN EXPRESSION; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CACHEXIA; CELLULAR IMMUNITY; COMBINATION CHEMOTHERAPY; CYTOKINE RELEASE; DENDRITIC CELL; DRUG DOSE INCREASE; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG MECHANISM; DRUG RECEPTOR BINDING; DRUG SAFETY; DRUG WITHDRAWAL; DYSPNEA; ENZYME ACTIVATION; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERURICEMIA; IMMUNOMODULATION; IMMUNOREGULATION; INTRACELLULAR SIGNALING; NATURAL KILLER CELL; NONHUMAN; RECOMMENDED DRUG DOSE; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; THORAX PAIN; VIRUS IMMUNITY; VIRUS REPLICATION;

EID: 79959956337     PISSN: 1570162X     EISSN: 18734251     Source Type: Journal    
DOI: 10.2174/157016211796320289     Document Type: Article

References (166)

1. Burnstock G. Purinergic nerves. Pharmacol Rev 1972; 24: 509-581.
2. Yip L, Woehrle T, Corriden R, Hirsh M, Chen Y, Inoue Y, et al. Autocrine regulation of T-cell activation by ATP release and P2X7 receptors. The Federation of American Societies for Experimental Biology 2009; 23; 1685-1693.
3. Huang N, Wang D, Heppel LA. Extracellular ATP is a mitogen for 3T3, 3T6, and A431 cells and actis synergistically with other growth factors. Proc Natl Acad Sci USA 1989; 86: 7904-7908.
4. Wagstaff SC, Bowler WB, Gallagher JA, Hipskind RA. Extracellular ATP activates multiple signalling pathways and potentiates growth factor-induced c-fos gene expression in MCF-7 breast cancer cells. Carcinogenesis 2000; 21: 2175-2181.
5. Colgan SP, Eltzschig HK, Eckle T, Thompson, LF. Physiologic roles for ecto-5-nucleotidase (CD73). Purinergic Signalling 2006; 2: 351-360.
6. Borsellino G, Kleinewietfeld M, Mitri, DD, Stemjak A, Diamantini A, Giometto R, Sabine Hopner, Centonze D, Bernardi G, Dell'Acqua ML, Rossini PM, Battistini L, Rotzschke O, Falk, K. Expression of ectonucleotidase CD39 by Foxp3+ Treg cells: hydrolysis of extracellular ATP and immune suppression. Blood 2008; 110: 1225-1232.
7. Deaglio S, Wenda Gao, Friedman D, et al. Adenosine generatioin catalzyed by CD39 and CD73 expressed on regulatory T cells mediates immune suppression. J Exp Med 2007; 204: 1257-1265.
8. Mandapathil M, Hilldorfer B, Szczepanski MJ, et al. Generation and Accumulation of immunosuppressive Adensoine by Human CD4+CD25 high FOXP3+ Regulatory T Cells. J Biol Chem 2010; 285: 7176-7186.
9. Dwyer KM, Deaglio S, Gao W, Friedman D, Strom TB, Robson SC. CD39 and control of cellular immune responses. Purinergic Signal 2007; 3: 171-180.
10. Bynoe MS, Viret C. Foxp3+CD4+ T cell-mediated immunosuppression involves extracellular nucleotide catabolism. Trends Immunol 2008; 29: 99-102.
11. Fountain SJ, Burnstock G. An evolutionary history of P2X receptors. Purinergic Signal 2009; 5: 269-272.
12. Fredholm BB, Lizerman AP, Jacobson KA, Klotz K.-N, Linden J. INternational Union of Pharmacology. XXV. Nomenclature and Classification of Adenosine Receptors. Pharmacol Rev 2001; 53: 527-552.
13. Wiley JS, Jamieson GP, Mayger WEJC Jr., Jopson M. Extracellular ATP Stimulates an Amiloride-Sensitive Sodium Influx in Human Lymphocytes. Arch Biochem Biophys 1990; 280: 263-268.
14. Schachter J, Piedade Motta A, de Souza Zamorano A, et al. ATPinduced P2X7-associated uptake of large molecules involves distinct mechanisms for cations and anions in macrophages. J Cell Sci 2008; 121: 3261-3270.
15. Hill LM, Gavala ML, Lenertz LY, Bertics PJ. Extracellular ATP may contribute to tissue repair by rapidly stimulating purinergic receptors X7-dependent vascular endothelial growth factor release from primary human monocytes. J Immunol 2010; 185: 3028-3034.
16. Erlinge D. Extracellular ATP: a Growth Factor for Vascular Smooth Muscle Cells. Gen Pharmacol 1998; 31; 108.
17. Neary JT, Whittmore SR, Zhu Q, Norenberg MD. Synergistic Activation of DNA Synthesis in Astrocytes by Fibroblast Growth Factors and Extracellular ATP. J Neurochem 1994; 63: 490-494.
18. Mishra SK, Braun N, Shukla V, Fullgrabe M, Schomerus C, Korf H.-W, Gachet C, Ikelhara, Y, Sevigny J, Robson SC, Zimmermann H. Extracellular nucleotide signaling in adult neural stem cells: synergism with growth factor-mediated cellular proliferation. Development 2005; 133: 675-684.
19. Gabel CA. P2 purinergic receptor modulation of cytokine production. Purinergic Signalling 2007; 3: 27-38.
20. Foresi NP, Laxalt AM, Tonon CV, Casalongue CA, Lamattina L. Extracellular ATP induces nitric oxide production in tomatoe cell suspensions. Plant Physiol 2007; 145: 589-592.
21. Czajkowski R, Baranska J. Cross-talk between ATP and ADP nucleotide receptor signalling pathways in glioma C6 cells. Acta Biochim Pol 2002; 49: 877-889.
22. Schenk U, Westendorf AM, Radaelli E, Casati A, Ferro M, Furnagalli M, Verderio C, Buer J, Scanziani E, Grassi F. Purinergic Control of T cell Activation by ATP released through Pannexin-1 Hemichannels. Science Signaling 2008; 1: 1-13.
23. Ekokoski, E. Extracellular ATP as a Regulator of Intracellular Signaling in Thyroid FRTL-5 Cells. In Department of Biosciences, Division of Animal Physiology, Volume PhDUniversity of Helsinki, Turku, Finland 73, 2000.
24. Huwiler A, Rolz W, Dorsch S, Ren S, Pfeilschifter J. Extracellular ATP and UTP activate the protein kinase B/Akt cascade via the P2Y2 purinoceptor in renal mesangial cells. Br J Pharmacol 2002; 136: 520-529.
25. Heo JS, Han HJ. ATP Stimulates Mouse Embryonic Stem Cell Proliferation via Protein Kinase C, Phosphantidylinositol 3-Kinase/Akt, and Mitogen-Activated Protein Kinase Signaling Pathways. Stem Cells 2006; 24: 2637-2648.
26. Dixon CJ, White PJ, Hall JF, Kingston S, Boarder, MR. Regulation of Human Hepatocytes by P2Y Receptors: Control of Glycogen Phosphorylase, Ca2+, and Mitogen-activated protein Kinase. J Pharmacol Exp Ther 2005; 313: 1305-1313.
27. Fujita N, Kakimi M, Ikeda Y, Hiramoto T, Sizuki K. Extracellular ATP inhibits starvation-induced apoptosis via P2X2 receptors in differentiated rat pheochromcytoma PC12 cells. Life Sci 2000; 66: 1849-1859.
28. Soltoff SP, Avraham H, Avraham S, Cantley LC. Activation of P2Y2 Receptors by UTP and ATP Stimulates Mitogen-activated Kinase Activity through a Pathway That Involves Related Adhesion Focal Tyrosine Kinase and Protein Kinase C. J Biol Chem 1998; 273: 2653-2660.
29. Cruz CMD, Ventura ALM, Schachter J, Costa-Junior HM, Antonio Da Silva Souza H, Gomes, FR, Coutinho-Silva R, Ojcius DM, Persechini PM. Activation of ERK 1/2 by extracellular nucleotides in macrophages is mediated by multiple P2 receptors independently of P2X7-associated pore or channel formation. Brit J Pharmacol 2006; 147: 324-334.
30. Wei S, Gamero AM, Liu JH, et al. Control of Lytic Function by Mitogen-activated Protein Kinaase/Extracellular Regulatory Kinase 2 (ERK2) in a Human Natural Killer Cell Line: identification of Perforin and Granzyme B Mobilization by Functional ERK2. J Exp Med 1998; 187: 1753-1765.
31. Di Virgilio F, Pizzo P, Zanovello P, Bronte V, Collavo D. Extracellular ATP as a possible mediator of cell-mediated cytotoxicty. Immunol Today 1990; 11: 274-277.
32. Van Der Weyden L, Conoigrave AD, Morris MB. Signal transduction and white cell maturation via extracellular ATP and the P2Y11 receptor. Immunol Cell Biol 2000; 78: 369-374.
33. Gerasimovskaya E, Kaczmarek E. Extracellular ATP and adenosine as regulators of endothelial cell function Implications for Health and Disease. Springer, 2010.
34. Foufelle F, Ferre P. Role of adenosine monophosphate-activated protein kinase in the control of energy homeostatis. Curr Opin Clin Nutr Metab Care 2005; 8: 355-360.
35. Pfielschifter J. Extracellular ATP stimulates polyphosphoinositide hydrolysis and prostaglandin synthesis in rat renal mesangial cells: Involvement of a pertussis toxin-sensitive guanine ucleotide binding protein and feedback inhibition by protein kinase C. Cell Signal 1990; 2: 129-138.
36. Hayes MM, Lane BR, King SR, Markovitz DM, Coffey MJ. Prostaglandin E2 inhibits replication of HIV-1 in marcrophages through activation of protein kinase A. Cell Immunol 2002; 215: 61-71.
37. Thivierge M, Le Gouill C, Tremblay MJ, Stankova J, Rola-Pleszcynski M. Prostaglandin E2 Induces Resistance to Human Immunodeficiency Virus-1 Infection in Monocyte-Derived Macrohages: Downregulation of CCR5 Expression by Cyclic Adenosine Monophosphate. Blood 1998; 92: 40-45.
38. Dumais N, Bardeau B, Olivier M, Tremblay MJ. Protaglandin E2 Up-regulates HIV-1 Long Terminal Repeat-driven Gene Activity in T cells via NF-αB-dependent and -Independent Signaling Pathways. J Biol Chem 1998; 273: 27306-27314.
39. Cahalan MD, Chandy KG. Ion channels in the immune system as targets for immunosuppression. Curr Opin Biotech; 1997; 8: 749-756.
40. Koles L, Gerevich Z, Oliveira JF, Zandori ZS, Wirkner K, Illes P. Interaction of P2 purinergic receptors with cellular macromolecules. Naunyn Schmiedebergs Arch Pharmacol 2008; 377: 1-33.
41. Yin J, Xu K, Zhang J, Kumar A, Yu F.-SX. Wound-induced ATP release and EGF receptor activation in epithelial cells. J Cell Sci 2007; 120: 815-825.
42. Madhusoodanan KS, Murad F. NO-cGMP signaling and regenerative medicine involving stem cells. Neurochem Res 2007; 32: 681-694.
43. Karunarathne W, Ku C.-J, Spence DM. The dual nature of extracellular ATP as a concentration-dependent platelet P2X1 agonist and antagonist. Integrative Biology 2009; 1: 655-663.
44. Nobles M, Abbott NJ. Decline of the calcium response on successive stimulation of a rat brain endothelial cell P2U purinoceptor. Acta Physiologica Scandinavica 1998; 162: 69-76.
45. Bles N, Horchmans M, Lefort A, Libert D, Macours P, Housni HE, Marteau F, Boeynaems J.-M, Communi D. Gene Expression Profiling Defines ATP as a Key Regulator of Human Dendritic Cell Functions. J Immunol 2007; 179: 3550-3558.
46. Gordon JL. Extracellular ATP: effects, sources and fate. Biochem J 1986; 233: 309-319.
47. Chen Y, Corriden R, Inoue Y, Yip L, Hashiguchi N, Zinkernagel A, Nizet V, insel PA, Junger, WG. ATP release guides neutrophil chemotaxis via P2Y2 and A3 receptors. Science 2006; 314: 1792-1795.
48. Loomis WH, Namiki S, Ostrom RS, Insel PA, Junger WG. Hypertonic Stress Increases T Cell Interleukin-2 Expression through a Mechanism That Involves ATP Release, P2 Receptor, and P38 MAPK Activation. J Biol Chem 2003; 278: 4590-4596.
49. Biswas D, Qureshi OS, Lee W.-Y, Croudace, JE, Mura M, Lammas DA. ATP-induced autophagy is associated with rapid killing of intracellular mycobacteria with human monocytes/macrophages. BMC Immunol 2008; 9: 35-45.
50. Saunders BM, Fernando SL, Sluyter R, Britton WJ, Wiley JS. A Loss-of-Function Polymorphism in the Human P2X7 Receptor Abolishes ATP-mediated Killing of Mycobacteria. J Immunol 2003; 171: 5442-5446.
51. Vance RE. Inflammasome Activation: How Macrophages Watch What They Eat. Cell Host and Microbe 2010; 3-5.
52. Bhardwaj R, Skelly PJ. Purinergic signaling and immune modulation at the schistosome surface. Trends Parasitol 2009; 6: 256-260.
53. Di Virgilio F. Purinergic mechanism in the immune system: A signal of danger for dendritic cells. Purinergic Signal 2005; 1: 205-209.
54. Feske S, Giltnane J, Dolmetsch R, Staudt LM, Rao A. Gene regulation mediated by Calcium Signals in T lymphocytes. Nature Immunol 2001; 2: 316-324.
55. Dwyer KM, Deaglio S, Wenda Gao, Friedman, D, Strom TB, Robson S. CD39 and control of cellular immune responses. Purinergic Signal 2007; 3: 171-180.
56. Liao H, Hyman MC, Baek AE, Fukase K, Pinsky DJ. CAMP/CREB-mediated transcriptional regulation of ectonucleoside triphosphate diphosphohyrolase 1 (CD39 expression. Journal of Biol Chem 2010; 285: 14791-14805.
57. Soslau G, Youngprapakorn D. A possilbe dual physiological role of extracellular ATP in the modulation of platelet aggregation. Biochimica et Biophysica Acta 1997; 1355: 131-140.
58. Nicholas RA. Identification of the P2Y12 receptor: a novel member of the P2Y family of receptors activated by extracellular nucleotides. Mol Pharmacol 2001; 60: 416-420.
59. Garcia J, Seabra A, Kennedy R, English A. Nitrite and nitroglycerin induced rapid release of the vasodilator ATP from erythrocytes: Relevance to the chemical physiology of local vasodilation. J Inorg Biochem 2010; 104: 289-296.
60. Filippini A, Taffs RE, Sitkovsky MV. Extracellular ATP in Tlymphocyte activation: Possible role in effector functions. Proc Natl Acad Sci USA 1990; 87: 8267-8271.
61. Smith BL, Krushelnycky BW, Mochly-Rosent D, Berg P. The HIV Nef protein associates with Protein Kinase C Theta. J Biol Chem 1996; 271: 16753-16757.
62. la Sala A, Ferrari D, Di Virgilio F, Idzko M, Norgauer J, Girolomoni G. Alerting and tuning the immune response by extracellular nucleotides. J Leukocyte Biol 2003; 73: 339-343.
63. Langston HP, Ke Y, Gewirtz AT, Dombrowski KE, Kapp JA. Secretion of IL-2 and IFN-{gamma}, but not IL-4, by antigenspecific T cells requires extracellular ATP. J Immunol 2010; 170: 2962-2970.
64. Rudin CM, Thompson CB. Apoptosis and disease: regulation and clinical relevance of programmed cell death. Annu Rev Med 1997; 48: 267-281.
65. Napolitano LA, Gran RM, Deeks SG, et al. Increased production of IL-7 accompanies HIV-1-mediated T-cell depletion: implications for T-cell homeostasis. Nature Med 2001; 7: 73-79.
66. Spranzi E, Djeu JY, Hoffman SL, Epling-Burnette PK, Blanchard DK. Lysis of human monocytic leukemia cells by extracellular Adenosine Triphosphate: mechanism and characterization of the Adenosine Triphosphate receptor. Blood 1993; 82: 1578-1585.
67. Zheng LM, Zychlinsky A, Liu, CC, Ojcius DM, Young JD. Extracellular ATP as a trigger for apoptosis or programmed cell death. J Cell Biol 1991; 112: 279-288.
68. Saleh M, Green DR. Caspase-1 inflammasomes: choosing between death and taxis. Cell Death Differ 2007; 14: 1559-1560.
69. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nat Rev Microbiol 2009; 7: 99-109.
70. Cruz CM, Rinna A, Forman HJ, Ventura ALM, Persechini PM, Ojcius DM. ATP activates a reactive oxygen species-dependent oxidative stress response and secretion of proinflammatory cytokines in macrophages. J Biol Chem 2007; 282: 2871-2879.
71. Piccini A, Carta S, Tassi S, Lasiglie D, Fossati G, Rubartelli A. ATP is released by monocytes stimulated with pathogen-sensing receptor ligands and induces IL-1α and IL-18 secretion in an autocrine way. Proc Natl Acad Sci USA 2008; 105: 8067-8072.
72. Surprenant A, North RA. Signaling at purinergic P2X receptors. Annu Rev Physiol 2009; 71: 333-359.
73. Marrack P, McKee AS, Munks MW. Box 2 / The NLRP3 inflammasome and the immunomodulatory activity of uric acid. Nature Rev 2009; 9: 287-293.
74. Ito M, Matsuoka I. Regulation of purinergic signaling by prostaglandin e2 in murine macrophages. J Pharm Sci 2008; 107: 443-450.
75. Gurcel L, Abrami L, Girardin S, Tschopp J, van der Goot FG. Caspase-1 Activation of lipid metabolic pathways in response to bacterial pore-forming toxins promotes cell survival. Cell 2006; 126: 1135-1145.
76. Bergsbaken T, Fink SL, Cookson BT. Pyroptosis: host cell death and inflammation. Nature Rev 2009; 7: 99-109.
77. von Albertini M, Palmetshofer A, Kaczmarek E, et al. Extracellular ATP and ADP activate transcription factor NF-κB and induce enothelial cell apaoptosis. Biochem Biophys Res Commun 1998; 248: 822-829.
78. Rathinam VAK, Fitzgerald KA. Inflammasomes and anti-viral immunity. J Clin Immunol; 2010; 30: 632-637.
79. Costa-Junior HM, Mendes AN, Davis GHNG, et al. ATP-induced apoptosis involves a Ca2+-independent phospholipase A2 and 5-lipoxygenase in macrophages. Prostaglandins Other Lipid Mediat 2009; 88: 51-61.
80. Higgins SC, Mills KHG. TLR, NLR Agonist, and other Immune modulators as infectious disease vaccine adjuvants. Curr Infect Dis Rep 2010; 12: 4-12.
81. Vatakis DN, Nixon CC, Zack JA. Quiescent T cells and HIV: an unresolved relationship. Immunol Res 2010; 48: 110-121.
82. Kukulski F, Yebdri FB, Lecka J., Kauffenstein G, Levesque SA, Martin-Statue M, Sevigny J. Extracellular ATP and P2 receptors are required for IL-8 to induce neutrophil migration. Cytokine 2009; 46: 166-170.
83. Seo DR, Kim KY, Lee YB. Interleukin-10 expression in lipopolysaccharide-activated microglia is mediated by extracellular ATP in an autocrine fashion. Neuroreport 2004; 15: 1157-1161.
84. Gu B, Bendall LJ, Wiley JS. Adenosine Triphosphate-induced shedding of CD23 and L-Selectin (CD62L) from lymphocytes is mediated by the same receptor but different metalloproteases. Blood 1998; 92: 946-951.
85. Haag F, Adriouch S, Brab A, et al. Extracellular NAD and ATP: Partners in immune cell modulation. Purinergic Signal 2007; 3: 71-81.
86. Weissmuller T, Eltzschig HK, Colgan SP. Dynamic purine signaling and metabolism during neutrophil-endothelial interactions. Purinergic Signal 2005; 1: 229-239.
87. Myrtek D, Idzko M. Chemotactic activity of extracellular nucleotides on human immune cells. Purinergic Signal 2007; 3: 5-11.
88. Barat C, Gilbert C, Imbeault M, Tremblay MJ. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Retrovirology 2008; 5: 30-45.
89. Rossi L, Manfredini R, Bertolini F, et al. The extracellular nucleotide UPT is a potent inducer of hematopoietic stem cell migration. Blood 2007; 109: 533-542.
90. Salmi M, Jalkanen S. Cell-surface enzymes in control of leukocyte trafficking. Nat Rev Immunol 2005; 5: 760-771.
91. Deli T, Csernoch L. Extracellular ATP and Cancer - an overview with special reference to P2 purinergic receptors. Pathol Oncol Res 2008; 14: 219-231.
92. Stagg J, Smyth M. Extracellular adenosine triphosphate and adenosine in cancer. Oncogene 2010; 29: 5346-5358.
93. Agteresch HJ, van Roojen MHC, Van den Berg JWO, Minderman-Voortman GJ, Wilson JHP, Dagnelie PC. Growth Inhibition of Lung Cancer Cells by Adenosine 5'-Triphosphate. Drug Develop Res 2003; 60: 196-203.
94. Dubyak GR, Fedan JS. Biological Actions Of Extracellular ATP. Volume 603 Annals Of The New York Academy Of Sciences 1990: 542.
95. Jacobson KA, Jarvis MF. Purinergic Approaches in Experimental Therapeutics. Wiley-Liss, New York, 1997: NY 10158-0012.
96. Jatoi A, Loprinzi CL, Sloan J, Goldberg RM. Is ATP (Adenosine 5'-Triphosphate) like STP, a performance-enhancing additive for the tanks of cancer patients? J Natl Cancer Inst 2000; 92: 290-291.
97. Agteresch HJ, Dagnelie PC, van den Berg JWO, Wilson JHP. Adenosine Triphosphate established and potential clinical applications. Drugs 1999; 58: 211-232.
98. Lemoli RM, Ferrari D, Fogli M, et al. Extracellular Nucleotides are potent stimulators of human hemopoetic stem cells in vitro and in vivo. Blood 2004; 104: 1662-1670.
99. Gerasimovskaya EV, Ahmad S, White CW, Jones PL, Carpenter TC, Stenmark KR. Extracellular ATP Is an Autocrin/Paracrin regulator of hypoxia-induced adventitial fibroblast growth. J Biol Chem 2002; 277: 44638-44650.
100. Schwiebert EM, Zsembery A. Extracellular ATP as a signaling molecule for epithelial cells. Biochemica et Biophysica Acta 2003; 1615: 7-32.
101. Gorini S, Sala Al. Hydrolysis of extracellular ATP and immune suppression: humans versus mice. Blood 2008; 111: 964-965.
102. Wu L, Paxton WA, Kassam N, et al. CCR5 levels and expression pattern correlate with infectability by macrophage-tropic HIV-1. J Exp Med 1997; 185: 1681-1691.
103. Ferrari D, Gulinelli S, Salvestrini V, et al. Purinergic stimulation of human mesenchymal stem cells potentiates their chemotactic response to CXCL12, increases the homing capacity and the production of pro-inflammatory cytokines. Exp Hematol 2010.
104. Sakowicz-Burkiewicz M, Kocbuch K, Grden M, Szutowicz A, Pawelczyk T. Adenosine 5'-Trphosphate is the predominant source of peripheral adenosine in human B lymphoblast. J Physiol Pharmacol 2010; 61: 491-499.
105. Katoh N. Platelets as versatile regulators of cutaneous inflammation. J Dermatol Sci 2009; 53: 89-95.
106. Balazovich K, Boxer L. Extracellular adenosine nucleotides stimulate protein kinase C activity and human neutrophil activation. J Immunol 1990; 144: 631-637.
107. Rapaport E. Utilization of ATP administration for the treatment of cancer and AIDS. Expert Opin Ther Pat 1994; 3: 379-389.
108. Hasko G, Linden J, Cronstein B, Pacher P. Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nature Rev 2008; 7, 759-770.
109. Saenger W. Principles of nucleic acid structure. In Springer Advanced Texts in Chemistry (C. R. Cantor, ed) Springer-Verlag, New York, Berlin, Heidelberg, Tokyo, 1984.
110. Shin YA, Eichorn GL. Interactions of Metal Ions with Polynucleotides and Related Compounds. XI. The Reversible Unwinding and Rewinding of Deoxyribonucleic Acid by Zinc (II) Ions through Temerpature Manipulation. Biochemistry 1968; 7: 1026-1032.
111. Kimber I, Cumberbatch M, Dearman RJ, Bhushan M, Griffiths CEM. Cytokines and chemokines in the intiation and regulation of epidermal Langerhans cell mobilization. Br Clin Dermatol 2000; 142: 401-412.
112. Marteau F, Gonzalez NS, Communi D, Goldman M, Boeynaems J.-M, Communi D. Thrombospondin-1 and indoleamine 3,3- dioxygenase are major targets of extracellular ATP in human dendritic cells. Blood 2005; 106: 3860-3866.
113. Idzko M, Hammad H, Nimwegen MV, Kool M, Willart MAM, Muskens F, Hoogsteden HC, Luttmann W, Ferrari D, Di Virgilio F Jr JCV, Lambrecht BN. Extracellular ATP triggers and maintains asthmatic airway inflammation by activating dendritic cells. Nature Med 2007; 13: 913-919.
114. la Sala A, Sebastiani S, Ferrari D, Di Virgilio F, Marco Idzko, Norgauer J, Girolomoni G. Dendritic cells exposed to extracellular adenosine triphosphate acquire the migratory porperties of mature cells and show a reduced capacity to attract type 1 T lymphoctyes. Blood 2002; 99: 1715-1722.
115. Barat C, Gilbert C, Imbeault M, Tremblay MJ. Extracellular ATP reduces HIV-1 transfer from immature dendritic cells to CD4+ T lymphocytes. Retrovirology 2008; 5: 30.
116. Rizzo R, Ferrari D, Melchiorri L, Stignani M, Gulinelli S, Baricordi OR, Di Virgilio F. Extracellular ATP Acting at the P2X7 Receptor Inhibits Secretion of Soluble HLA-G from Human Monocytes. J Immunol 2009; 183: 4302-4311.
117. Crombie R. Mechanism of Thrombospondin-1 Anti-HIV-1 Activity. Aids Patient Care ST 2000; 14: 211-214.
118. Taraboletti G, Benelli R, Borsotti P, et al. Thrombospondin-1 Inhibits Kaposi's Sarcoma (KS) cell and HIV-1 Tat-Induced Angiogenesis and is Poorly Expressed in KS Lesions. J Pathol 1999; 188: 76-81.
119. Kumar V, Sharma A. Adenosine: An endogenous modulator of innate immune system with therapeutic potential. Eur J Pharmacol 2009; 616: 7-15.
120. Kfutwah AK, Mary J.-Y, Nicola M.-A, Blaise-Boisseau S, Barre-Sinoussi F, Ayouba A, Menu, E. Tumour necrosis Factor-a stimulates HIV-1 replication in single-cycle infection of human term placental villi fragments in a time, viral dose and envelope dependent manner. Retrovirology 2006; 3: 36.
121. Weissman D, Poli G, Fauci AS. Interleuking 10 Blocks HIV Replication in Macrophages by Inhibiting the Autocrine Loop of Tumor Necrosis Factor αand Interleukin 6 Induction of Virus. AIDS Res Hum Retroviruses 2009; 10: 1199-1206.
122. Mannick JB, Stamler JS, Teng E, et al. Nitric Oxide Modulates HIV-1 Replication. J Acquir Immune Defic Syndr 1999; 22: 1-9.
123. Haskell CM, Mendoza E, Pisters KMW, Fossella FV, Figlin RA. Phase II study of intravenous adenosine 5'-triphosphate in patients with previously untreated stage IIIB and Stage IV non-small cell lung cancer. Investigational New Drugs 1998; 16: 81-85.
124. Agteresch HJ, Burgers SA, van der Gaast A, Wilson JH, Dagnelie PC. Randomized clinical trial of adenosine 5'-triphosphate on tumor growth and survival in advanced lung cancer patients. Anticancer Drugs 2003; 14: 639-644.
125. Agteresch HJ., Dagnelie PC, van der Gaast A, Stijnen T, Wilson JHP. Randomized Clinical Trial of Adenosine 5'-Triphosphate in Patients With Advanced Non-Snall-Cell Lung Cancer. J Natl Cancer Inst 2000; 92: 321-328.
126. Fishman P, Bar-Yehuda S, Farbstein T, Barer F, Ohana G. Adenosine Acts as a Chemoprotective Agent by Stimulating GCSF Production: A Role for A1 and A3 Adenosine Receptors. J Cell Physiol 2000; 183: 393-398.
127. Yegutkin GG, Henttinen T, Samburski SS, Spychala J, Jalkanen S. The evidence for tow opposite ATP-generating and ATPconsuming extracellular pathways on endothelial and lymphoid cells. Biochem J 2002; 367: 121-128.
128. Cammalleri L, Malaguarnera M. Rasburicase represents a new tool for hyperuricemia in tumor lysis syndrome and in gout. Int J Med Sci 2007; 4: 83-93.
129. Eltzschig HK, Faigle M, Knapp S, et al. Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 2006; 108: 1602-1610.
130. Zimmermann H. Extracellular Purine Metabolism. Drug Develop Res 1996; 39: 337-352.
131. Koshiba M, Rosin DL, Hayashi N, Linden J, Sitkovsky MV. Patterns of A2A extraceullar adenosine receptor expression in different functional subsets of human peripheral T Cells. Flow Cytometry Studies With Anti-A2A Receptor Monoclonal Antibodies. Mol Pharmacol 1999; 55: 614-624.
132. Fletcher JM, Lonergan R, Costelloe L, et al. CD39+Foxp3+ Regulatory T Cells Suppress Pathogenic Th17 Cells and Are Impaired in Multiple Sclerosis. J Immunol 2009; 183: 7602-7610.
133. Agteresch HJ, Dagnelie PC, Rietveld T, Van den Berg JWO, Danser AHJ, WIlson JHP. Pharmacokinetics of intravenous ATP in cancer patients. Eur J Pharmacol; 2000; 56: 49-55.
134. Hogquist KA, Nett MA, Unanue ER, Chaplin DD. Interleukin 1 is processed and released during apoptosis. Proc Natl Acad Sci USA 1991; 88: 8485-8489.
135. Ferrari D, Pizzirani C, Adinolfi E, et al. The P2X7 Receptor: a key player in il-1 processing and release. J Immunol 2006; 176: 3877-3883.
136. Ferrari D, La Sala A, Chiozzi P, et al. The P2 purinergic receptors of human dendritic cells: identification and coupling to cytokine release. Fed Am Soc Exp Biol 2000; 14: 2466-2476.
137. Trautmann A. Extracellular ATP in the Immune System: More Than Just a Danger Signal. Science Signal 2009; 2: 1-3.
138. Di Virgilio F. Purinergic Signalling in the immune system. A brief update. Purinergic Signal 2007; 3: 1-3.
139. Serenzani CH, Ballinger MN, Aronoff DM, Peters-Golden M. Cyclic AMP Master Regulator of Innate Immune Cell Function. Am J Respir Cell Mol Biol; 2008; 39: 127-132.
140. Erdmann AA, Gao Z.-G, Jung U, Foley J, Borenstein T, Jacobson KA, Fowler DH. Activation of Th1 and Tc1 cell adenosine A2A receptors directly inhibits IL-2 secretion in vitro and IL-2 driven expansion in vivo. Blood 2005; 105: 4704-4714.
141. Meldrum DR, Ayala A, Wang P, Ertel W, Chaudry IH. Association between decreased splenic ATP levels and immunodepression: amelioration with ATP-MgCl2. Am J Physiol 1991; 261: R351-R357.
142. Duhant X, Schandene L, Bruyns C, Gonzalez NS, Goldman M, Boeynaems J.-M, Communi D. Extracellular Adenine Nucleotides Inhibit the Activation of Human CD4+ T Lymphocytes. J Immunol 2002; 169: 15-21.
143. Palaga T, Kataoka T, Nagai K. Extracellular ATP inhibits apoptosis and maintains cell viability by inducing autocrin production of interleukin-4 in a myeloid progenitor cell line. Int Immunopharmacol 2004; 4: 953-961.
144. Wang P, Ba ZF, Morrison MH, Ayala A, Dean RE, Chaudry IH. Mechanism of the Beneficial Effects of ATP-MgCl2 following Trauma-Hemorrhage and Resuscitation: Downregulation of Inflammatory Cytokines (TNF, IL-6) Release. Journal of Surgical Research 1992; 52: 364-371.
145. Caraccio N, Monzani F, Santini E, Cuccato S, Ferrari D, Callegari MG, Gulinelli S, Pizzirani, C, Di Virgilio F, Ferrannini E, Solini A. Extracellular adenosine 5'-triphosphate modulates Interleukin-6 production by human thyrocytes through functional purinergic P2 receptors. Endocrinology 2005; 146: 3172-3178.
146. Hanley PJ, Musset B, Reniguanta V, et al. Extracellular ATP induces oscillations of intracellular Ca and membran potential and promotes transcription of IL-6 in macrophages. Proc Natl Acad Sci USA 2004; 101: 9479-9484.
147. Shigemoto-Mogami Y, Koizumi S, Tsuda M, Ohsawa K, Kohsaka S, Inoue K. Mechanisms underlying extracellular ATP-evoked interleukin-6 release in mouse microglial cell line, MG-5. J Neurochem 2001; 78: 1339-1349.
148. Inoue K, Hosoi J, Denda M. Extracellular ATP has stimulatory effects on the expression and release of IL-6 via purnergic receptors in normal human epidernal keratinocytes. J Invest Dermatol 2007; 127: 362-371.
149. Warny M, Aboudol, S, Robson SC, Sevigny J, Sommuni D, Soltoff SP, Kelly CP. P2Y6 Nucleotide Receptor Mediates Monocytes Interleukin-8 Production in Response to UDP or Lipopolysaccharide. J Biol Chem 2001; 276: 26051-26056.
150. Hasko G, Szabo C, Nemeth ZH, Kvetan B, McCarthy Pastores S, Vizi ES. Adenosine Receptor Agnosts Differentially Regulate IL-10, TNF-α, and Nitric Oxide Production in RAW 264.7 Macrophages and in Endotoxemic Mice. J Immunol 1996; 157: 4634-4640.
151. Tilley SL, Boucher RC. A1 antagonism in asthma: better than coffee? J Clin Invest 2005; 115: 13-16.
152. Seo D, Kim S, Kim K, Lee H, Moon J, Lee J, Lee S, Kim S, Lee Y. Cross talk between P2 purinergic receptors modulates extracellular ATP-mediated interleukin-10 production in rat microglial cells. Exp Mol Med 2008; 40: 19-26.
153. Beijer S, Hupperets PS, van den Borne BE, et al. Effects of adenosine 5'-triphosphate infusions on the nutritional status and survival of preterminal cancer patients. Anticancer Drugs 2009; 20: 625-633.
154. Schnurr M, Toy T, Shin A, Wagner M, Cebon J, Maraskovsky E. Extracellular nucleotide signaling by P2 receptors inhibits IL-12 and enhances IL-23 expression in human dendritic cells: a novel role for the cAMP pathway. Blood 2005; 105: 1582-1589.
155. Hasko G, Kuhel DG, Salzman AL, Szabo C. ATP suppression of interleukin-12 and tumour necrosis factor-αrelease from macrophages. Br J Pharmacol 2009; 129: 909-914.
156. Luna C, Li G, Qui J, Challa P, Epstein DL, Gonzalez P. Extracellular Release of ATP Mediated. by Cyclic Mechanical Stress Leads to Mobilization of AA in Trabecular Meshwork Cells. Invest Ophthalmol Vis Sci 2009; 50: 5805-5810.
157. Motte S, Communi D, Pirotton S, Boeynaems J.-M. Involvement of Multiple Receptors in the Actions of Extracellular ATP: the Example of Vascular Endothelial Cells. Int J Biochem Cell Biol 1995; 27: 1-7.
158. Enjyoji K, Sevigny J, Lin Y, et al. Targeted disruption of cd39/ATP diphosphohydrolase results in disordered hemostasis and thromboregulation. Nature Med 1999; 5: 1010-1017.
159. Khakh BS, North RA. P2X receptors as cell-surface ATP sensors in health and disease. Nature 2006; 442: 527-532.
160. Wang ECY, Lee J.-M, Ruiz WG, Balestreire EM, Von Bodugen M, Barrick S, Cockayne, DA, Birder LA, Apodaca G. ATP and purinergic receptor-dependent membrane traffic in bladder umbrella cells. J Clin Invest 2005; 115: 2412-2422.
161. Sluyter R, Wiley JS. Extracellular adenosine 5'-triphosphate induces a loss of CD23 from human dendritic cells via activation of P2X7 receptors. Int Immunol 2002; 14: 1415-1421.
162. Fine J, Cole P, Davidson JS. Extracellular nucleotides stimulate receptor-mediated calcium mobilization and inositol phosphate production in human fibroblasts. Biochem J 1989; 263: 371-376.
163. Schofl C, Ponczek M, Mader T, et al. Regulation of cytosolic free calcium concentration by extracellular nucleotides in human hepatocytes. Am J Physiol Gastrointest Liver Physiol 1999; 276: G164-G172.
164. Koshiba M, Kojima H, Huang S, Apasov S, Sitkovsky MV. Memory of extracellular Adensoine A2A Purinergic receptormediated signaling in murine T Cells. J Biol Chem 1997; 272: 25881-25889.
165. Sexl V, Mancusi G, Holler C, Gloria-Maercker E, Schutz W, Freissmuth M. Stimulation of the Mitogen-activated Protein Kinase via the A2A-Adenosine Receptor in Primary Human Endothelial Cells. J Biol Chem 1997; 272: 5792-5799.
166. Dahl SV, Wettstein M, Gerok W, Haussinger D. Stimulation of relsease of prostaglandin D2 and thromboxane B2 from perfused rat liver by extracellular adenosine. Biochem J 1990; 270: 39-44.